- ARPA-H bookmarks $160M for custom gene editing treatments. Is it enough?After an infant last year was saved from a deadly disease thanks to a bespoke gene editing therapy that fixed an incredibly rare mutation in his DNA, the US government is hoping ...Endpoints · 17d ago↗ source
- HHS advances plan to pay out Covid-19 vaccine injury claimsA newly proposed HHS rule would establish a compensation mechanism for people who claim they were injured by Covid-19 vaccines, as a key panel that oversees broader vaccine injury payments remains…Endpoints · 17d ago↗ source
- Roche ends work on tominersen after decade of trials, as well as early-stage Huntington’s assetAfter more than a decade of work and plenty of ups and downs, Roche has dropped its Huntington’s disease drug tominersen. The decision comes after tominersen did no better than placebo in a Phase…